Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | September 06, 2016

D.Ariz excludes expert for not apportioning the rate, but OKs entire product as base

Blog | August 27, 2016

Medical Diagnostic Tests — Are They Patentable? Don't Count On It.

Blog | August 25, 2016

DDE excludes settlement agreements; allows licenses as a "check"; addresses apportionment of accused products & services

Blog | August 19, 2016

Dancing Baby May Be Headed To Supreme Court

Blog | August 19, 2016

USPTO Announces Updates to Accelerated Examination Program

Blog | August 19, 2016

SDFL allows opinion based in part on plaintiff's licensing proposals (or offers)

Blog | August 17, 2016

EDTX questions viability of "inexorable flow" doctrine of lost profits

Blog | August 16, 2016

Federal Circuit Once Again Finds That a Functional Claim Term is Indefinite Even Without the Use of "Means."

Blog | August 15, 2016

Federal Circuit Going En Banc on IPR Standards for Amending

Blog | August 15, 2016

NDCA excludes expert testimony for failure to apportion (including addressing claim scope argument)

Blog | August 11, 2016

Apotex Takes Aim at Amgen Patent in IPR Petition After Being Sued Under the BPCIA

Blog | August 11, 2016

WDWI rejects "inexorable flow" doctrine of lost profits